NYSE : AORT
Artivion, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 23.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.14B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.10B |
| Enterprise Value | 1.43B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 48.76M |
| Shares Outstanding | 48.76M |
| Shares Change (YoY) | +12.42% |
| Shares Change (QoQ) | -2.39% |
| Owned by Insiders (%) | 5.07% |
| Owned by Institutions (%) | 97.49% |
| Float | 46.28M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 220.94 |
| PS Ratio | 2.34 |
| Forward PS | 2.13 |
| PB Ratio | 2.47 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 26.39 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 3.04 |
| EV / EBITDA | 22.47 |
| EV / EBIT | 36.56 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.47 |
| Quick Ratio | 1.76 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | 5.72 |
| Debt / FCF | n/a |
| Interest Coverage | 1.61 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -0.73% |
| Return on Assets (ROA) | 2.56% |
| Return on Invested Capital (ROIC) | -7.77% |
| Return on Capital Employed (ROCE) | 4.06% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | $261,930 |
| Profits Per Employee | -$1,773 |
| Employee Count | 1,800 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.77 |
Taxes
| Measure | Value |
|---|
| Income Tax | 5.40M |
| Effective Tax Rate | 241.74% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -49.81% |
| 50-Day Moving Average | 23.87 |
| 200-Day Moving Average | 29.39 |
| Relative Strength Index (RSI) | 46.58 |
| Average Volume (20 Days) | 490,926 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.74M |
| Short Previous Month | 3.28M |
| Short % of Shares Out | 7.66% |
| Short % of Float | 8.07% |
| Short Ratio (days to cover) | 6.21 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 471.47M |
| Gross Profit | 303.50M |
| Operating Income | 39.15M |
| Pretax Income | 2.23M |
| Net Income | -3.19M |
| EBITDA | 63.72M |
| EBIT | 39.15M |
| Loss Per Share | -$0.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 77.32M |
| Total Debt | 407.97M |
| Net Cash | -330.65M |
| Net Cash Per Share | -$6.78 |
| Equity (Book Value) | 445.59M |
| Book Value Per Share | 9.15 |
| Working Capital | 264.45M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 41.71M |
| Capital Expenditures | -50.87M |
| Depreciation & Amortization | 24.56M |
| Net Borrowing | 145.66M |
| Free Cash Flow | -9.16M |
| FCF Per Share | -$0.19 |
Margins
| Measure | Value |
|---|
| Gross Margin | 64.37% |
| Operating Margin | 8.30% |
| Pretax Margin | 0.47% |
| Profit Margin | -0.67% |
| EBITDA Margin | 13.51% |
| EBIT Margin | 8.30% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.42% |
| Shareholder Yield | -12.42% |
| Earnings Yield | -0.30% |
| FCF Yield | -0.83% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $40.91 |
| Price Target Difference | 81.18% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 11.37% |
| EPS Growth Forecast (3Y) | 19.13% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 28, 2000 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |